Details of the Drug

General Information of Drug (ID: DM2XC05)

Drug Name
Latrunculin B
Synonyms INS-115644; Cytoskeleton-targeting compounds (glaucoma), Wisconsin Alumni Research Foundation (WARF)/Inspire
Indication
Disease Entry ICD 11 Status REF
Glaucoma/ocular hypertension 9C61 Phase 1 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C20H29NO5S
Canonical SMILES
CC1CCC2CC(CC(O2)(C3CSC(=O)N3)O)OC(=O)C=C(CCC=C1)C
InChI
1S/C20H29NO5S/c1-13-5-3-4-6-14(2)9-18(22)25-16-10-15(8-7-13)26-20(24,11-16)17-12-27-19(23)21-17/h3,5,9,13,15-17,24H,4,6-8,10-12H2,1-2H3,(H,21,23)/b5-3-,14-9-/t13-,15-,16-,17+,20-/m1/s1
InChIKey
NSHPHXHGRHSMIK-JRIKCGFMSA-N
Cross-matching ID
PubChem CID
6436219
ChEBI ID
CHEBI:49703
CAS Number
76343-94-7
TTD ID
D07EHB

References

1 ClinicalTrials.gov (NCT00443924) Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma. U.S. National Institutes of Health.